FDA Recalls 40,000 Bottles of Clear Eyes Drops Over Sterility Concerns

Exactly 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief are currently being pulled from store shelves across the United States. The U.S. Food and Drug Administration (FDA) has flagged the 15-milliliter dropper bottles for a "lack of assurance of sterility," prompting a nationwide Class II recall.[1][2]

For consumers, the immediate actionable takeaway is to check medicine cabinets for a specific batch. The recall is limited to a single production run: lot number 2552A, which carries an expiration date of September 30, 2027. The product is identifiable by the National Drug Code (NDC) 67172-999-01 and UPC 6 78112 65920 3. Anyone possessing a bottle from this lot is instructed to stop using it immediately and return it to the place of purchase for a full refund.[1][2][4][5]

The recall was voluntarily initiated on July 29, 2026, by Prestige Consumer Healthcare, the New York-based parent company of distributor Medtech Products Inc. By August 14, the FDA formally classified the action as a Class II recall. This designation means that while the product could cause temporary or medically reversible adverse health consequences, the probability of serious, lasting harm is considered remote.[1][2][3][4]

Understanding the exact nature of the FDA's "lack of assurance of sterility" warning is critical for assessing the risk. The phrasing indicates a procedural or manufacturing failure rather than confirmed contamination. The manufacturer cannot definitively guarantee that the drops are entirely free from harmful microorganisms, such as bacteria or fungi, due to a breakdown in quality control or testing protocols.[3][5]

As of late August, no adverse health events or specific infections have been linked to this lot of Clear Eyes. The product is not actively known to contain a pathogen. However, because the manufacturer cannot prove the absolute absence of microbes, the FDA treats the batch as potentially contaminated to prevent any risk of ocular infection.[1][3]

Sterility is a non-negotiable safety standard for ophthalmic products because the human eye is uniquely vulnerable to infection. Unlike oral medications, which pass through the highly acidic environment of the stomach, eye drops are applied directly to the conjunctiva and cornea. These tissues lack the robust immune defenses found in the digestive tract, allowing introduced bacteria to multiply rapidly.[5][6]

When contaminated liquid is instilled into the eye, it can bypass the body's primary barriers. In severe cases, bacterial or fungal keratitis can develop—an infection of the cornea that can lead to scarring, vision impairment, or even blindness if left untreated. While the FDA considers the risk of such severe outcomes remote for this specific Class II recall, the baseline danger of non-sterile eye products remains high.[1][2][5]

The Clear Eyes recall is part of a broader, ongoing regulatory crackdown on over-the-counter eye care products. In 2023, the FDA recalled EzriCare Artificial Tears after the product was linked to a severe outbreak of Pseudomonas aeruginosa, a drug-resistant bacterium. That contamination resulted in at least one death, 68 injuries, and several cases where patients required surgical removal of the infected eye.[2]

Since that landmark outbreak, federal regulators have significantly tightened their oversight of ophthalmic manufacturing facilities. Earlier in August 2026, a separate recall affected over 12 million bottles of Rohto Cooling Eye Drops—also citing a "lack of assurance of sterility." In March, K.C. Pharmaceuticals pulled more than 3 million bottles of lubricating eye drops for similar quality control failures.[4]

For shoppers navigating the eye care aisle, these consecutive recalls highlight the importance of batch tracking and regulatory compliance. Clear Eyes Maximum Itchy Eye Relief is a widely distributed product, sold at major national retailers including Walmart, Target, Kroger, Dollar General, and Family Dollar. The sheer volume of the distribution network means that affected bottles could be in hundreds of thousands of households.[2][4]

The product itself is marketed as an astringent and lubricant designed to relieve redness, itching, burning, and watery eyes caused by environmental irritants. Its active ingredients include a redness reliever and an astringent to reduce inflammation. Consumers who rely on these drops for daily relief are advised to switch to alternative, unaffected lots or different brands while the recall is processed.[2][3][5]

If a consumer has already used a bottle from lot 2552A, medical professionals advise monitoring for any unusual symptoms. Signs of a potential ocular infection include increased redness, pain, discharge, sensitivity to light, or sudden changes in vision. Anyone experiencing these symptoms after using the recalled drops should seek immediate evaluation from an optometrist or ophthalmologist.[2][5]